Login / Signup

Examination of Prognostic Factors in Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis.

Suzuna SugiMasaki TominagaShinjiro KaiedaKiminori FujimotoTomonori ChikasueTakuma KogaYuri HasuoErina IwanagaKenta MurotaniJamie Kristen T LimHiroaki IdaTomotaka KawayamaTomoaki Hoshino
Published in: Modern rheumatology (2024)
Four weeks after beginning treatment, serum CRP and albumin levels of patients with MDA5-DM can be used to evaluate treatment response and predict prognosis.
Keyphrases